Stifel Nicolaus Keeps Their Buy Rating on Pyxis Oncology (PYXS)
In a report released on March 21, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with ...
Stifel Nicolaus Has Lowered Expectations for Vor Biopharma (NYSE:VOR) Stock Price
Vor Biopharma (NYSE:VOR – Get Free Report) had its price target lowered by equities researchers at Stifel Nicolaus from ...
Financial Advisor12d
Stifel Ordered To Pay Nearly $133M To Family Over Risky Structured Notes
Stifel, Nicolaus & Company Inc. has been ordered by an arbitration panel to pay a family of four investors more than $132 million for breach of fiduciary duty and negligence tied to risky ...